Manu Platt talks about the new NIH Center for Biomedical Engineering Technology Acceleration

Area of Science:

• Biomedical Engineering
• Biotechnology
• Health Sciences

Background:

• The National Institute of Biomedical Imaging and Bioengineering (NIBIB) recognizes the need for accelerated translation of engineering innovations into clinical practice.
• Existing pathways for biomedical technology development can be slow and face challenges in equitable access.

Purpose of the Study:

• To announce the establishment of the Center for Biomedical Engineering Technology Acceleration (BETA).
• To outline the Center's mission to apply engineering principles to accelerate biomedical discovery and therapeutic development.
• To highlight the Center's commitment to diversity, equity, inclusion, and accessibility (DEIA) in its operations and impact.

Main Methods:

• Informal communication and discussion with the Center's Director, Manu Platt.
• Description of the Center's strategic focus and operational plans.
• Emphasis on the integration of DEIA principles into the Center's framework.

Main Results:

• The Center for Biomedical Engineering Technology Acceleration has been officially established.
• A clear strategic direction has been set, focusing on engineering-driven biomedical innovation.
• DEIA is a foundational element of the Center's mission and operational strategy.

Conclusions:

• The NIBIB's new Center for BETA is poised to significantly impact biomedical innovation.
• The focus on DEIA aims to ensure broader participation and benefit from technological advancements.
• This initiative represents a proactive approach to overcoming barriers in biomedical technology translation.